Eagle Bay Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Eagle Bay Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-160	Closed	-$11K	–	1037
2022 Q3	$11K	Hold	160	–	–	0.01%	592
2022 Q2	$5.11K	Buy	+160	New	+$4.68K	﹤0.01%	719
2022 Q1	–	Sell	-80	Closed	-$2K	–	1052
2021 Q4	$2K	Buy	+80	New	+$2.48K	﹤0.01%	957

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eagle Bay Advisors's GBT Position: Q4 2022 in Review

Eagle Bay Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 160 shares — an estimated $11K sold.

Eagle Bay Advisors first reported a position in GBT in Q4 2021 and held it in 3 quarters. The position peaked at $11K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Eagle Bay Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Eagle Bay Advisors sold 160 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $11K.
Eagle Bay Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 3 quarters.
Eagle Bay Advisors's Global Blood Therapeutics, Inc. position peaked at $11K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Eagle Bay Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.